The Challenges and Opportunities of Going Global--In-depth Dialogue with Chinese Biopharma Companies
CEIBS Global EMBA programme, ranked #2 worldwide for four consecutive years by the Financial Times, invites you to attend our symposium on The Challenges and Opportunities of Going Global on May 22 in Beijing.
About this event
Chuhai - a term used to describe Chinese companies expanding abroad - has become a buzz word this year, and seems to offer a solution for companies looking to offset slowing domestic consumption and a long winter for China's capital market. The internationalization of a firm, however, is a significant undertaking and commitment that requires overcoming numerous challenges, from commercial development to transformation of governance models. At this event, we invite you to join a sharing session with ACRObiosystems and Pharmaron, two Chinese biopharma companies which generate a majority of their revenue from international markets and are in different stages of the arduous and exciting process of internationalization.
This event is an opportunity to learn
- How to deploy international business from scratch
- Traps and lessons learned in cross-border M&A
- How to build an HR strategy amidst global competition
- Strategies for business model transformation
About our speaker
Gilbert Li
CFO, Pharmaron
Global EMBA 2010
Mr. Gilbert Li is Pharmaron's Chief Financial Officer and Board Secretary. Gilbert joined Pharmaron in January 2008 and is responsible for the overall finance function, strategic acquisitions and investor relationships of the company. Gilbert is a CFA charter holder and member of the HKICPA and AICPA. He is the CEIBS alumni from GEMBA 2010.
Pharmaron (Stock Code: 300759.SZ/3759.HK) is a premier R&D service provider for the life sciences industry. Founded in 2004, Pharmaron has invested in its people and facilities, and established a broad spectrum of research, development and manufacturing service capabilities throughout the entire drug discovery, preclinical and clinical development process across multiple therapeutic modalities, including small molecules, biologics and cell & gene therapy products. With over 20,000 employees, and 21 operating sites across China, UK and US, Pharmaron has an excellent track record in the delivery of R&D solutions to its partners globally.
Mike Chen
Founder & CEO, ACROBiosystems
Global EMBA 2021
Mr. Mike Chen, Chairman and CEO of ACRObiosystems, founded the company in July 2010 and grew the business from its first day to a multinational organization. He has 20+ years of experience in the life science industry and has various titles in Entrepreneurship. He is the CEIBS alumni from GEMBA 2021. ACROBiosystems (Stock Code:301080) founded in 2010, is a biotechnology company aimed at being a cornerstone of the global biopharmaceutical and health industries by providing products and innovative solutions. The company spans the globe and maintains offices, R&D centers, and production bases in over 10 different cities within the United States, Switzerland, England and Germany. Among its 9000+ worldwide customers, ACROBiosystems Group has established numerous long-term and stable partnerships with the world’s top pharmaceutical enterprises, including Pfizer, Novartis, and Johnson & Johnson, and numerous well-known academic institutes. The company comprises several subsidiaries such as ACROBiosystems, bioSeedin, Condense Capital, and ACRODiagnostics.
Prof. Eric Bouteiller
Adjunct Professor of Management, CElBS
Adjunct professor of management at CEIBS with a focus on healthcare industries, Dr Eric Bouteiller has also a successful experience of business leadership as GM for China and Senior Vice President Asia for IPSEN Pharma. During his tenure he has developed a business organization covering whole Asia. He was involved in several prominent business organizations in China, like ‘European Union Chamber of Commerce in China’ (EUCCC) and ‘Research & Development Pharmaceutical Association of China’ (RDPAC). Eric research mainly focuses on corporate strategy, market access and public policies for pharmaceutical and healthcare industries. He advises several international companies in their development in Healthcare in China and Asia.
Event details
Date & Time: May 22nd, Wednesday, 2024 at 18:30 to 21:30
Venue: Reignwood Fairmont Beijing Hotel
Language: Bilingual (English and Chinese)
Contact: Click the link below to register or contact Alex Chen at calex@ceibs.edu or call 021-28905321 for more information.
Agenda
18:30-19:00 Registration and Networking
19:00-19:10 Opening and Introduction to the CEIBS Global EMBA Programme
19:10-20:25 Panel Discussion – The Challenges and Opportunities of Going Global
20:25-20:45 Q&A
20:45-21:30 Networking
